nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—HTR2A—Alzheimer's disease	0.138	0.522	CbGaD
Risperidone—CYP2D6—Alzheimer's disease	0.126	0.478	CbGaD
Risperidone—HTR2A—Donepezil—Alzheimer's disease	0.0964	0.296	CbGbCtD
Risperidone—DRD2—Memantine—Alzheimer's disease	0.077	0.237	CbGbCtD
Risperidone—CYP2D6—Rivastigmine—Alzheimer's disease	0.0401	0.123	CbGbCtD
Risperidone—CYP2D6—Donepezil—Alzheimer's disease	0.0321	0.0986	CbGbCtD
Risperidone—CYP3A4—Rivastigmine—Alzheimer's disease	0.0255	0.0784	CbGbCtD
Risperidone—CYP2D6—Galantamine—Alzheimer's disease	0.0207	0.0635	CbGbCtD
Risperidone—CYP3A4—Donepezil—Alzheimer's disease	0.0204	0.0627	CbGbCtD
Risperidone—CYP3A4—Galantamine—Alzheimer's disease	0.0131	0.0404	CbGbCtD
Risperidone—HTR2C—choroid plexus—Alzheimer's disease	0.00752	0.0977	CbGeAlD
Risperidone—DRD3—telencephalic ventricle—Alzheimer's disease	0.00396	0.0515	CbGeAlD
Risperidone—HTR2A—choroid plexus—Alzheimer's disease	0.00377	0.049	CbGeAlD
Risperidone—HTR7—locus ceruleus—Alzheimer's disease	0.00374	0.0486	CbGeAlD
Risperidone—DRD1—telencephalic ventricle—Alzheimer's disease	0.00284	0.0369	CbGeAlD
Risperidone—HTR2A—locus ceruleus—Alzheimer's disease	0.00233	0.0303	CbGeAlD
Risperidone—HTR1B—telencephalic ventricle—Alzheimer's disease	0.0023	0.0299	CbGeAlD
Risperidone—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00222	0.0289	CbGeAlD
Risperidone—HTR2C—telencephalic ventricle—Alzheimer's disease	0.0022	0.0286	CbGeAlD
Risperidone—HTR2A—cerebellar cortex—Alzheimer's disease	0.0019	0.0247	CbGeAlD
Risperidone—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00185	0.0241	CbGeAlD
Risperidone—HTR7—telencephalic ventricle—Alzheimer's disease	0.00177	0.023	CbGeAlD
Risperidone—DRD2—telencephalic ventricle—Alzheimer's disease	0.00168	0.0218	CbGeAlD
Risperidone—Iloperidone—HTR6—Alzheimer's disease	0.0013	0.422	CrCbGaD
Risperidone—HTR1B—blood vessel—Alzheimer's disease	0.00114	0.0148	CbGeAlD
Risperidone—HTR2A—telencephalic ventricle—Alzheimer's disease	0.0011	0.0144	CbGeAlD
Risperidone—HTR1D—blood vessel—Alzheimer's disease	0.0011	0.0143	CbGeAlD
Risperidone—HTR7—blood vessel—Alzheimer's disease	0.000877	0.0114	CbGeAlD
Risperidone—H1F0—embryo—Alzheimer's disease	0.000848	0.011	CbGeAlD
Risperidone—H1F0—forebrain—Alzheimer's disease	0.00075	0.00975	CbGeAlD
Risperidone—DRD1—forebrain—Alzheimer's disease	0.00074	0.00962	CbGeAlD
Risperidone—H1F0—telencephalon—Alzheimer's disease	0.00069	0.00896	CbGeAlD
Risperidone—DRD1—telencephalon—Alzheimer's disease	0.000681	0.00885	CbGeAlD
Risperidone—DRD4—brain—Alzheimer's disease	0.00061	0.00793	CbGeAlD
Risperidone—HTR1B—forebrain—Alzheimer's disease	0.0006	0.0078	CbGeAlD
Risperidone—HTR1D—forebrain—Alzheimer's disease	0.000581	0.00755	CbGeAlD
Risperidone—HTR2C—forebrain—Alzheimer's disease	0.000575	0.00748	CbGeAlD
Risperidone—DRD3—nervous system—Alzheimer's disease	0.000561	0.0073	CbGeAlD
Risperidone—HTR1B—telencephalon—Alzheimer's disease	0.000552	0.00717	CbGeAlD
Risperidone—Paliperidone—HTR2A—Alzheimer's disease	0.000547	0.178	CrCbGaD
Risperidone—HTR2A—blood vessel—Alzheimer's disease	0.000547	0.00711	CbGeAlD
Risperidone—DRD3—central nervous system—Alzheimer's disease	0.00054	0.00702	CbGeAlD
Risperidone—HTR2B—forebrain—Alzheimer's disease	0.00054	0.00702	CbGeAlD
Risperidone—HTR1D—telencephalon—Alzheimer's disease	0.000534	0.00694	CbGeAlD
Risperidone—HTR2C—telencephalon—Alzheimer's disease	0.000529	0.00687	CbGeAlD
Risperidone—Paliperidone—CYP2D6—Alzheimer's disease	0.0005	0.162	CrCbGaD
Risperidone—HTR2B—telencephalon—Alzheimer's disease	0.000497	0.00646	CbGeAlD
Risperidone—HTR1A—forebrain—Alzheimer's disease	0.000484	0.00629	CbGeAlD
Risperidone—HTR7—forebrain—Alzheimer's disease	0.000463	0.00601	CbGeAlD
Risperidone—ADRA1A—forebrain—Alzheimer's disease	0.000446	0.0058	CbGeAlD
Risperidone—HTR1A—telencephalon—Alzheimer's disease	0.000445	0.00579	CbGeAlD
Risperidone—DRD2—forebrain—Alzheimer's disease	0.000437	0.00569	CbGeAlD
Risperidone—ADRA1B—nervous system—Alzheimer's disease	0.000431	0.0056	CbGeAlD
Risperidone—KCNH2—forebrain—Alzheimer's disease	0.000431	0.0056	CbGeAlD
Risperidone—DRD3—brain—Alzheimer's disease	0.000429	0.00558	CbGeAlD
Risperidone—HTR7—telencephalon—Alzheimer's disease	0.000425	0.00553	CbGeAlD
Risperidone—ADRA1B—central nervous system—Alzheimer's disease	0.000415	0.0054	CbGeAlD
Risperidone—ADRA1A—telencephalon—Alzheimer's disease	0.00041	0.00533	CbGeAlD
Risperidone—H1F0—nervous system—Alzheimer's disease	0.000407	0.00529	CbGeAlD
Risperidone—DRD2—telencephalon—Alzheimer's disease	0.000402	0.00523	CbGeAlD
Risperidone—DRD1—nervous system—Alzheimer's disease	0.000402	0.00522	CbGeAlD
Risperidone—KCNH2—telencephalon—Alzheimer's disease	0.000396	0.00515	CbGeAlD
Risperidone—H1F0—central nervous system—Alzheimer's disease	0.000392	0.00509	CbGeAlD
Risperidone—ADRA2C—telencephalon—Alzheimer's disease	0.000391	0.00508	CbGeAlD
Risperidone—DRD1—central nervous system—Alzheimer's disease	0.000387	0.00503	CbGeAlD
Risperidone—H1F0—cerebellum—Alzheimer's disease	0.000383	0.00498	CbGeAlD
Risperidone—Iloperidone—HTR2A—Alzheimer's disease	0.000383	0.124	CrCbGaD
Risperidone—ABCB1—blood vessel—Alzheimer's disease	0.000358	0.00466	CbGeAlD
Risperidone—Iloperidone—CYP2D6—Alzheimer's disease	0.00035	0.114	CrCbGaD
Risperidone—HRH1—forebrain—Alzheimer's disease	0.000345	0.00449	CbGeAlD
Risperidone—ADRA2A—forebrain—Alzheimer's disease	0.000339	0.00441	CbGeAlD
Risperidone—ADRA1B—brain—Alzheimer's disease	0.00033	0.00428	CbGeAlD
Risperidone—HTR2A—embryo—Alzheimer's disease	0.000326	0.00424	CbGeAlD
Risperidone—HTR1B—nervous system—Alzheimer's disease	0.000326	0.00423	CbGeAlD
Risperidone—HRH1—telencephalon—Alzheimer's disease	0.000318	0.00413	CbGeAlD
Risperidone—HTR1D—nervous system—Alzheimer's disease	0.000315	0.0041	CbGeAlD
Risperidone—HTR1B—central nervous system—Alzheimer's disease	0.000314	0.00408	CbGeAlD
Risperidone—HTR2C—nervous system—Alzheimer's disease	0.000312	0.00406	CbGeAlD
Risperidone—ADRA2A—telencephalon—Alzheimer's disease	0.000312	0.00406	CbGeAlD
Risperidone—H1F0—brain—Alzheimer's disease	0.000311	0.00404	CbGeAlD
Risperidone—DRD1—brain—Alzheimer's disease	0.000307	0.00399	CbGeAlD
Risperidone—HTR1D—central nervous system—Alzheimer's disease	0.000304	0.00395	CbGeAlD
Risperidone—HTR2C—central nervous system—Alzheimer's disease	0.000301	0.00391	CbGeAlD
Risperidone—HTR2B—nervous system—Alzheimer's disease	0.000293	0.00381	CbGeAlD
Risperidone—HTR2A—forebrain—Alzheimer's disease	0.000289	0.00375	CbGeAlD
Risperidone—HTR2B—central nervous system—Alzheimer's disease	0.000282	0.00367	CbGeAlD
Risperidone—HTR2A—telencephalon—Alzheimer's disease	0.000265	0.00345	CbGeAlD
Risperidone—CYP2D6—forebrain—Alzheimer's disease	0.000263	0.00342	CbGeAlD
Risperidone—HTR1A—nervous system—Alzheimer's disease	0.000263	0.00342	CbGeAlD
Risperidone—HTR1A—central nervous system—Alzheimer's disease	0.000253	0.00329	CbGeAlD
Risperidone—HTR7—nervous system—Alzheimer's disease	0.000251	0.00326	CbGeAlD
Risperidone—HTR1B—brain—Alzheimer's disease	0.000249	0.00324	CbGeAlD
Risperidone—HTR1A—cerebellum—Alzheimer's disease	0.000247	0.00321	CbGeAlD
Risperidone—ADRA1A—nervous system—Alzheimer's disease	0.000242	0.00315	CbGeAlD
Risperidone—HTR7—central nervous system—Alzheimer's disease	0.000242	0.00314	CbGeAlD
Risperidone—CYP2D6—telencephalon—Alzheimer's disease	0.000242	0.00314	CbGeAlD
Risperidone—HTR1D—brain—Alzheimer's disease	0.000241	0.00313	CbGeAlD
Risperidone—HTR2C—brain—Alzheimer's disease	0.000239	0.0031	CbGeAlD
Risperidone—DRD2—nervous system—Alzheimer's disease	0.000237	0.00309	CbGeAlD
Risperidone—HTR7—cerebellum—Alzheimer's disease	0.000236	0.00307	CbGeAlD
Risperidone—KCNH2—nervous system—Alzheimer's disease	0.000234	0.00304	CbGeAlD
Risperidone—ADRA1A—central nervous system—Alzheimer's disease	0.000233	0.00303	CbGeAlD
Risperidone—ADRA2C—nervous system—Alzheimer's disease	0.000231	0.003	CbGeAlD
Risperidone—DRD2—central nervous system—Alzheimer's disease	0.000229	0.00297	CbGeAlD
Risperidone—ADRA1A—cerebellum—Alzheimer's disease	0.000228	0.00296	CbGeAlD
Risperidone—KCNH2—central nervous system—Alzheimer's disease	0.000225	0.00293	CbGeAlD
Risperidone—HTR2B—brain—Alzheimer's disease	0.000224	0.00291	CbGeAlD
Risperidone—DRD2—cerebellum—Alzheimer's disease	0.000223	0.0029	CbGeAlD
Risperidone—ADRA2C—central nervous system—Alzheimer's disease	0.000222	0.00289	CbGeAlD
Risperidone—KCNH2—cerebellum—Alzheimer's disease	0.00022	0.00286	CbGeAlD
Risperidone—ADRA2C—cerebellum—Alzheimer's disease	0.000217	0.00282	CbGeAlD
Risperidone—ABCB1—embryo—Alzheimer's disease	0.000214	0.00278	CbGeAlD
Risperidone—HTR1A—brain—Alzheimer's disease	0.000201	0.00261	CbGeAlD
Risperidone—HTR7—brain—Alzheimer's disease	0.000192	0.0025	CbGeAlD
Risperidone—ABCB1—forebrain—Alzheimer's disease	0.000189	0.00246	CbGeAlD
Risperidone—HRH1—nervous system—Alzheimer's disease	0.000188	0.00244	CbGeAlD
Risperidone—ADRA1A—brain—Alzheimer's disease	0.000185	0.00241	CbGeAlD
Risperidone—ADRA2A—nervous system—Alzheimer's disease	0.000184	0.00239	CbGeAlD
Risperidone—DRD2—brain—Alzheimer's disease	0.000182	0.00236	CbGeAlD
Risperidone—HRH1—central nervous system—Alzheimer's disease	0.000181	0.00235	CbGeAlD
Risperidone—KCNH2—brain—Alzheimer's disease	0.000179	0.00232	CbGeAlD
Risperidone—ADRA2A—central nervous system—Alzheimer's disease	0.000177	0.00231	CbGeAlD
Risperidone—ADRA2C—brain—Alzheimer's disease	0.000176	0.00229	CbGeAlD
Risperidone—ABCB1—telencephalon—Alzheimer's disease	0.000174	0.00226	CbGeAlD
Risperidone—ADRA2A—cerebellum—Alzheimer's disease	0.000173	0.00225	CbGeAlD
Risperidone—HTR2A—nervous system—Alzheimer's disease	0.000157	0.00204	CbGeAlD
Risperidone—HTR2A—central nervous system—Alzheimer's disease	0.000151	0.00196	CbGeAlD
Risperidone—HTR2A—cerebellum—Alzheimer's disease	0.000147	0.00192	CbGeAlD
Risperidone—CYP3A4—nervous system—Alzheimer's disease	0.000145	0.00188	CbGeAlD
Risperidone—HRH1—brain—Alzheimer's disease	0.000143	0.00186	CbGeAlD
Risperidone—CYP2D6—nervous system—Alzheimer's disease	0.000143	0.00185	CbGeAlD
Risperidone—ADRA2A—brain—Alzheimer's disease	0.000141	0.00183	CbGeAlD
Risperidone—CYP3A4—central nervous system—Alzheimer's disease	0.00014	0.00181	CbGeAlD
Risperidone—CYP2D6—central nervous system—Alzheimer's disease	0.000137	0.00179	CbGeAlD
Risperidone—CYP2D6—cerebellum—Alzheimer's disease	0.000134	0.00175	CbGeAlD
Risperidone—HTR2A—brain—Alzheimer's disease	0.00012	0.00156	CbGeAlD
Risperidone—CYP2D6—brain—Alzheimer's disease	0.000109	0.00142	CbGeAlD
Risperidone—ABCB1—nervous system—Alzheimer's disease	0.000103	0.00133	CbGeAlD
Risperidone—ABCB1—central nervous system—Alzheimer's disease	9.88e-05	0.00128	CbGeAlD
Risperidone—Urethral disorder—Memantine—Alzheimer's disease	9.81e-05	0.000401	CcSEcCtD
Risperidone—Haemorrhage—Rivastigmine—Alzheimer's disease	9.79e-05	0.000401	CcSEcCtD
Risperidone—Hepatitis—Rivastigmine—Alzheimer's disease	9.79e-05	0.000401	CcSEcCtD
Risperidone—Hyperhidrosis—Galantamine—Alzheimer's disease	9.76e-05	0.0004	CcSEcCtD
Risperidone—Hypoaesthesia—Rivastigmine—Alzheimer's disease	9.74e-05	0.000399	CcSEcCtD
Risperidone—Alopecia—Donepezil—Alzheimer's disease	9.74e-05	0.000399	CcSEcCtD
Risperidone—Pharyngitis—Rivastigmine—Alzheimer's disease	9.71e-05	0.000398	CcSEcCtD
Risperidone—Urinary tract disorder—Rivastigmine—Alzheimer's disease	9.66e-05	0.000396	CcSEcCtD
Risperidone—ABCB1—cerebellum—Alzheimer's disease	9.66e-05	0.00126	CbGeAlD
Risperidone—Mental disorder—Donepezil—Alzheimer's disease	9.65e-05	0.000395	CcSEcCtD
Risperidone—Oedema peripheral—Rivastigmine—Alzheimer's disease	9.64e-05	0.000395	CcSEcCtD
Risperidone—Visual impairment—Memantine—Alzheimer's disease	9.64e-05	0.000395	CcSEcCtD
Risperidone—Anorexia—Galantamine—Alzheimer's disease	9.63e-05	0.000394	CcSEcCtD
Risperidone—Connective tissue disorder—Rivastigmine—Alzheimer's disease	9.62e-05	0.000394	CcSEcCtD
Risperidone—Urethral disorder—Rivastigmine—Alzheimer's disease	9.59e-05	0.000393	CcSEcCtD
Risperidone—Erythema—Donepezil—Alzheimer's disease	9.59e-05	0.000393	CcSEcCtD
Risperidone—Malnutrition—Donepezil—Alzheimer's disease	9.59e-05	0.000393	CcSEcCtD
Risperidone—Erythema multiforme—Memantine—Alzheimer's disease	9.46e-05	0.000387	CcSEcCtD
Risperidone—Flatulence—Donepezil—Alzheimer's disease	9.45e-05	0.000387	CcSEcCtD
Risperidone—Hypotension—Galantamine—Alzheimer's disease	9.44e-05	0.000386	CcSEcCtD
Risperidone—Visual impairment—Rivastigmine—Alzheimer's disease	9.43e-05	0.000386	CcSEcCtD
Risperidone—Tension—Donepezil—Alzheimer's disease	9.41e-05	0.000385	CcSEcCtD
Risperidone—Dysgeusia—Donepezil—Alzheimer's disease	9.39e-05	0.000384	CcSEcCtD
Risperidone—Eye disorder—Memantine—Alzheimer's disease	9.35e-05	0.000383	CcSEcCtD
Risperidone—Tinnitus—Memantine—Alzheimer's disease	9.33e-05	0.000382	CcSEcCtD
Risperidone—Nervousness—Donepezil—Alzheimer's disease	9.32e-05	0.000381	CcSEcCtD
Risperidone—Cardiac disorder—Memantine—Alzheimer's disease	9.28e-05	0.00038	CcSEcCtD
Risperidone—Flushing—Memantine—Alzheimer's disease	9.28e-05	0.00038	CcSEcCtD
Risperidone—Back pain—Donepezil—Alzheimer's disease	9.28e-05	0.00038	CcSEcCtD
Risperidone—Erythema multiforme—Rivastigmine—Alzheimer's disease	9.25e-05	0.000379	CcSEcCtD
Risperidone—Muscle spasms—Donepezil—Alzheimer's disease	9.22e-05	0.000377	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	9.2e-05	0.000377	CcSEcCtD
Risperidone—Eye disorder—Rivastigmine—Alzheimer's disease	9.15e-05	0.000374	CcSEcCtD
Risperidone—Insomnia—Galantamine—Alzheimer's disease	9.14e-05	0.000374	CcSEcCtD
Risperidone—Tinnitus—Rivastigmine—Alzheimer's disease	9.12e-05	0.000374	CcSEcCtD
Risperidone—Cardiac disorder—Rivastigmine—Alzheimer's disease	9.08e-05	0.000372	CcSEcCtD
Risperidone—Flushing—Rivastigmine—Alzheimer's disease	9.08e-05	0.000372	CcSEcCtD
Risperidone—Angiopathy—Memantine—Alzheimer's disease	9.08e-05	0.000372	CcSEcCtD
Risperidone—Paraesthesia—Galantamine—Alzheimer's disease	9.07e-05	0.000371	CcSEcCtD
Risperidone—Vision blurred—Donepezil—Alzheimer's disease	9.04e-05	0.00037	CcSEcCtD
Risperidone—Immune system disorder—Memantine—Alzheimer's disease	9.04e-05	0.00037	CcSEcCtD
Risperidone—Mediastinal disorder—Memantine—Alzheimer's disease	9.02e-05	0.000369	CcSEcCtD
Risperidone—Tremor—Donepezil—Alzheimer's disease	8.99e-05	0.000368	CcSEcCtD
Risperidone—Somnolence—Galantamine—Alzheimer's disease	8.98e-05	0.000368	CcSEcCtD
Risperidone—Chills—Memantine—Alzheimer's disease	8.98e-05	0.000367	CcSEcCtD
Risperidone—Arrhythmia—Memantine—Alzheimer's disease	8.94e-05	0.000366	CcSEcCtD
Risperidone—Ill-defined disorder—Donepezil—Alzheimer's disease	8.9e-05	0.000364	CcSEcCtD
Risperidone—Dyspepsia—Galantamine—Alzheimer's disease	8.89e-05	0.000364	CcSEcCtD
Risperidone—Angiopathy—Rivastigmine—Alzheimer's disease	8.88e-05	0.000363	CcSEcCtD
Risperidone—Anaemia—Donepezil—Alzheimer's disease	8.86e-05	0.000363	CcSEcCtD
Risperidone—Alopecia—Memantine—Alzheimer's disease	8.84e-05	0.000362	CcSEcCtD
Risperidone—Mediastinal disorder—Rivastigmine—Alzheimer's disease	8.82e-05	0.000361	CcSEcCtD
Risperidone—Agitation—Donepezil—Alzheimer's disease	8.81e-05	0.000361	CcSEcCtD
Risperidone—Chills—Rivastigmine—Alzheimer's disease	8.78e-05	0.000359	CcSEcCtD
Risperidone—Decreased appetite—Galantamine—Alzheimer's disease	8.78e-05	0.000359	CcSEcCtD
Risperidone—Mental disorder—Memantine—Alzheimer's disease	8.76e-05	0.000359	CcSEcCtD
Risperidone—Arrhythmia—Rivastigmine—Alzheimer's disease	8.74e-05	0.000358	CcSEcCtD
Risperidone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	8.72e-05	0.000357	CcSEcCtD
Risperidone—Malnutrition—Memantine—Alzheimer's disease	8.71e-05	0.000356	CcSEcCtD
Risperidone—Fatigue—Galantamine—Alzheimer's disease	8.71e-05	0.000356	CcSEcCtD
Risperidone—Malaise—Donepezil—Alzheimer's disease	8.65e-05	0.000354	CcSEcCtD
Risperidone—Alopecia—Rivastigmine—Alzheimer's disease	8.65e-05	0.000354	CcSEcCtD
Risperidone—Constipation—Galantamine—Alzheimer's disease	8.64e-05	0.000354	CcSEcCtD
Risperidone—Vertigo—Donepezil—Alzheimer's disease	8.62e-05	0.000353	CcSEcCtD
Risperidone—Syncope—Donepezil—Alzheimer's disease	8.6e-05	0.000352	CcSEcCtD
Risperidone—Flatulence—Memantine—Alzheimer's disease	8.58e-05	0.000351	CcSEcCtD
Risperidone—Mental disorder—Rivastigmine—Alzheimer's disease	8.57e-05	0.000351	CcSEcCtD
Risperidone—Tension—Memantine—Alzheimer's disease	8.55e-05	0.00035	CcSEcCtD
Risperidone—Dysgeusia—Memantine—Alzheimer's disease	8.53e-05	0.000349	CcSEcCtD
Risperidone—Malnutrition—Rivastigmine—Alzheimer's disease	8.52e-05	0.000349	CcSEcCtD
Risperidone—Erythema—Rivastigmine—Alzheimer's disease	8.52e-05	0.000349	CcSEcCtD
Risperidone—Nervousness—Memantine—Alzheimer's disease	8.46e-05	0.000346	CcSEcCtD
Risperidone—Loss of consciousness—Donepezil—Alzheimer's disease	8.43e-05	0.000345	CcSEcCtD
Risperidone—Back pain—Memantine—Alzheimer's disease	8.42e-05	0.000345	CcSEcCtD
Risperidone—Flatulence—Rivastigmine—Alzheimer's disease	8.39e-05	0.000344	CcSEcCtD
Risperidone—Cough—Donepezil—Alzheimer's disease	8.37e-05	0.000343	CcSEcCtD
Risperidone—Tension—Rivastigmine—Alzheimer's disease	8.36e-05	0.000342	CcSEcCtD
Risperidone—Dysgeusia—Rivastigmine—Alzheimer's disease	8.34e-05	0.000341	CcSEcCtD
Risperidone—Feeling abnormal—Galantamine—Alzheimer's disease	8.32e-05	0.000341	CcSEcCtD
Risperidone—Convulsion—Donepezil—Alzheimer's disease	8.31e-05	0.00034	CcSEcCtD
Risperidone—Hypertension—Donepezil—Alzheimer's disease	8.28e-05	0.000339	CcSEcCtD
Risperidone—Nervousness—Rivastigmine—Alzheimer's disease	8.27e-05	0.000339	CcSEcCtD
Risperidone—Gastrointestinal pain—Galantamine—Alzheimer's disease	8.26e-05	0.000338	CcSEcCtD
Risperidone—Back pain—Rivastigmine—Alzheimer's disease	8.24e-05	0.000337	CcSEcCtD
Risperidone—Vision blurred—Memantine—Alzheimer's disease	8.21e-05	0.000336	CcSEcCtD
Risperidone—Muscle spasms—Rivastigmine—Alzheimer's disease	8.19e-05	0.000335	CcSEcCtD
Risperidone—Arthralgia—Donepezil—Alzheimer's disease	8.17e-05	0.000334	CcSEcCtD
Risperidone—Chest pain—Donepezil—Alzheimer's disease	8.17e-05	0.000334	CcSEcCtD
Risperidone—Myalgia—Donepezil—Alzheimer's disease	8.17e-05	0.000334	CcSEcCtD
Risperidone—Tremor—Memantine—Alzheimer's disease	8.16e-05	0.000334	CcSEcCtD
Risperidone—Anxiety—Donepezil—Alzheimer's disease	8.14e-05	0.000333	CcSEcCtD
Risperidone—Ill-defined disorder—Memantine—Alzheimer's disease	8.08e-05	0.000331	CcSEcCtD
Risperidone—Discomfort—Donepezil—Alzheimer's disease	8.07e-05	0.00033	CcSEcCtD
Risperidone—Anaemia—Memantine—Alzheimer's disease	8.05e-05	0.000329	CcSEcCtD
Risperidone—Vision blurred—Rivastigmine—Alzheimer's disease	8.03e-05	0.000329	CcSEcCtD
Risperidone—Agitation—Memantine—Alzheimer's disease	8e-05	0.000328	CcSEcCtD
Risperidone—Dry mouth—Donepezil—Alzheimer's disease	7.99e-05	0.000327	CcSEcCtD
Risperidone—Body temperature increased—Galantamine—Alzheimer's disease	7.98e-05	0.000327	CcSEcCtD
Risperidone—Abdominal pain—Galantamine—Alzheimer's disease	7.98e-05	0.000327	CcSEcCtD
Risperidone—Tremor—Rivastigmine—Alzheimer's disease	7.98e-05	0.000327	CcSEcCtD
Risperidone—Ill-defined disorder—Rivastigmine—Alzheimer's disease	7.9e-05	0.000324	CcSEcCtD
Risperidone—Confusional state—Donepezil—Alzheimer's disease	7.89e-05	0.000323	CcSEcCtD
Risperidone—Anaemia—Rivastigmine—Alzheimer's disease	7.87e-05	0.000322	CcSEcCtD
Risperidone—Malaise—Memantine—Alzheimer's disease	7.85e-05	0.000321	CcSEcCtD
Risperidone—ABCB1—brain—Alzheimer's disease	7.85e-05	0.00102	CbGeAlD
Risperidone—Agitation—Rivastigmine—Alzheimer's disease	7.83e-05	0.00032	CcSEcCtD
Risperidone—Oedema—Donepezil—Alzheimer's disease	7.83e-05	0.00032	CcSEcCtD
Risperidone—Vertigo—Memantine—Alzheimer's disease	7.82e-05	0.00032	CcSEcCtD
Risperidone—Syncope—Memantine—Alzheimer's disease	7.81e-05	0.00032	CcSEcCtD
Risperidone—Leukopenia—Memantine—Alzheimer's disease	7.8e-05	0.000319	CcSEcCtD
Risperidone—Infection—Donepezil—Alzheimer's disease	7.78e-05	0.000318	CcSEcCtD
Risperidone—Shock—Donepezil—Alzheimer's disease	7.7e-05	0.000315	CcSEcCtD
Risperidone—Palpitations—Memantine—Alzheimer's disease	7.7e-05	0.000315	CcSEcCtD
Risperidone—Malaise—Rivastigmine—Alzheimer's disease	7.68e-05	0.000314	CcSEcCtD
Risperidone—Nervous system disorder—Donepezil—Alzheimer's disease	7.68e-05	0.000314	CcSEcCtD
Risperidone—Thrombocytopenia—Donepezil—Alzheimer's disease	7.66e-05	0.000314	CcSEcCtD
Risperidone—Vertigo—Rivastigmine—Alzheimer's disease	7.65e-05	0.000313	CcSEcCtD
Risperidone—Loss of consciousness—Memantine—Alzheimer's disease	7.65e-05	0.000313	CcSEcCtD
Risperidone—Syncope—Rivastigmine—Alzheimer's disease	7.64e-05	0.000313	CcSEcCtD
Risperidone—Cough—Memantine—Alzheimer's disease	7.6e-05	0.000311	CcSEcCtD
Risperidone—Hyperhidrosis—Donepezil—Alzheimer's disease	7.57e-05	0.00031	CcSEcCtD
Risperidone—Convulsion—Memantine—Alzheimer's disease	7.55e-05	0.000309	CcSEcCtD
Risperidone—Palpitations—Rivastigmine—Alzheimer's disease	7.53e-05	0.000308	CcSEcCtD
Risperidone—Hypertension—Memantine—Alzheimer's disease	7.52e-05	0.000308	CcSEcCtD
Risperidone—Loss of consciousness—Rivastigmine—Alzheimer's disease	7.49e-05	0.000307	CcSEcCtD
Risperidone—Anorexia—Donepezil—Alzheimer's disease	7.46e-05	0.000305	CcSEcCtD
Risperidone—Hypersensitivity—Galantamine—Alzheimer's disease	7.44e-05	0.000305	CcSEcCtD
Risperidone—Cough—Rivastigmine—Alzheimer's disease	7.43e-05	0.000304	CcSEcCtD
Risperidone—Arthralgia—Memantine—Alzheimer's disease	7.41e-05	0.000303	CcSEcCtD
Risperidone—Chest pain—Memantine—Alzheimer's disease	7.41e-05	0.000303	CcSEcCtD
Risperidone—Myalgia—Memantine—Alzheimer's disease	7.41e-05	0.000303	CcSEcCtD
Risperidone—Anxiety—Memantine—Alzheimer's disease	7.39e-05	0.000302	CcSEcCtD
Risperidone—Convulsion—Rivastigmine—Alzheimer's disease	7.38e-05	0.000302	CcSEcCtD
Risperidone—Hypertension—Rivastigmine—Alzheimer's disease	7.36e-05	0.000301	CcSEcCtD
Risperidone—Discomfort—Memantine—Alzheimer's disease	7.33e-05	0.0003	CcSEcCtD
Risperidone—Hypotension—Donepezil—Alzheimer's disease	7.31e-05	0.000299	CcSEcCtD
Risperidone—Arthralgia—Rivastigmine—Alzheimer's disease	7.25e-05	0.000297	CcSEcCtD
Risperidone—Myalgia—Rivastigmine—Alzheimer's disease	7.25e-05	0.000297	CcSEcCtD
Risperidone—Chest pain—Rivastigmine—Alzheimer's disease	7.25e-05	0.000297	CcSEcCtD
Risperidone—Dry mouth—Memantine—Alzheimer's disease	7.25e-05	0.000297	CcSEcCtD
Risperidone—Asthenia—Galantamine—Alzheimer's disease	7.25e-05	0.000297	CcSEcCtD
Risperidone—Anxiety—Rivastigmine—Alzheimer's disease	7.23e-05	0.000296	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	7.2e-05	0.000295	CcSEcCtD
Risperidone—Confusional state—Memantine—Alzheimer's disease	7.17e-05	0.000293	CcSEcCtD
Risperidone—Discomfort—Rivastigmine—Alzheimer's disease	7.17e-05	0.000293	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	7.13e-05	0.000292	CcSEcCtD
Risperidone—Oedema—Memantine—Alzheimer's disease	7.11e-05	0.000291	CcSEcCtD
Risperidone—Dry mouth—Rivastigmine—Alzheimer's disease	7.09e-05	0.00029	CcSEcCtD
Risperidone—Insomnia—Donepezil—Alzheimer's disease	7.08e-05	0.00029	CcSEcCtD
Risperidone—Infection—Memantine—Alzheimer's disease	7.06e-05	0.000289	CcSEcCtD
Risperidone—Paraesthesia—Donepezil—Alzheimer's disease	7.03e-05	0.000288	CcSEcCtD
Risperidone—Confusional state—Rivastigmine—Alzheimer's disease	7.01e-05	0.000287	CcSEcCtD
Risperidone—Shock—Memantine—Alzheimer's disease	6.99e-05	0.000286	CcSEcCtD
Risperidone—Dyspnoea—Donepezil—Alzheimer's disease	6.98e-05	0.000286	CcSEcCtD
Risperidone—Nervous system disorder—Memantine—Alzheimer's disease	6.97e-05	0.000285	CcSEcCtD
Risperidone—Somnolence—Donepezil—Alzheimer's disease	6.96e-05	0.000285	CcSEcCtD
Risperidone—Thrombocytopenia—Memantine—Alzheimer's disease	6.96e-05	0.000285	CcSEcCtD
Risperidone—Oedema—Rivastigmine—Alzheimer's disease	6.95e-05	0.000285	CcSEcCtD
Risperidone—Tachycardia—Memantine—Alzheimer's disease	6.94e-05	0.000284	CcSEcCtD
Risperidone—Diarrhoea—Galantamine—Alzheimer's disease	6.91e-05	0.000283	CcSEcCtD
Risperidone—Infection—Rivastigmine—Alzheimer's disease	6.91e-05	0.000283	CcSEcCtD
Risperidone—Skin disorder—Memantine—Alzheimer's disease	6.9e-05	0.000283	CcSEcCtD
Risperidone—Dyspepsia—Donepezil—Alzheimer's disease	6.89e-05	0.000282	CcSEcCtD
Risperidone—Hyperhidrosis—Memantine—Alzheimer's disease	6.87e-05	0.000281	CcSEcCtD
Risperidone—Shock—Rivastigmine—Alzheimer's disease	6.84e-05	0.00028	CcSEcCtD
Risperidone—Nervous system disorder—Rivastigmine—Alzheimer's disease	6.82e-05	0.000279	CcSEcCtD
Risperidone—Thrombocytopenia—Rivastigmine—Alzheimer's disease	6.81e-05	0.000279	CcSEcCtD
Risperidone—Decreased appetite—Donepezil—Alzheimer's disease	6.8e-05	0.000279	CcSEcCtD
Risperidone—Tachycardia—Rivastigmine—Alzheimer's disease	6.79e-05	0.000278	CcSEcCtD
Risperidone—Anorexia—Memantine—Alzheimer's disease	6.77e-05	0.000277	CcSEcCtD
Risperidone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	6.76e-05	0.000277	CcSEcCtD
Risperidone—Skin disorder—Rivastigmine—Alzheimer's disease	6.75e-05	0.000276	CcSEcCtD
Risperidone—Fatigue—Donepezil—Alzheimer's disease	6.75e-05	0.000276	CcSEcCtD
Risperidone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	6.72e-05	0.000275	CcSEcCtD
Risperidone—Pain—Donepezil—Alzheimer's disease	6.69e-05	0.000274	CcSEcCtD
Risperidone—Constipation—Donepezil—Alzheimer's disease	6.69e-05	0.000274	CcSEcCtD
Risperidone—Dizziness—Galantamine—Alzheimer's disease	6.68e-05	0.000273	CcSEcCtD
Risperidone—Hypotension—Memantine—Alzheimer's disease	6.64e-05	0.000272	CcSEcCtD
Risperidone—Anorexia—Rivastigmine—Alzheimer's disease	6.63e-05	0.000271	CcSEcCtD
Risperidone—Hypotension—Rivastigmine—Alzheimer's disease	6.5e-05	0.000266	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	6.48e-05	0.000265	CcSEcCtD
Risperidone—Feeling abnormal—Donepezil—Alzheimer's disease	6.45e-05	0.000264	CcSEcCtD
Risperidone—Insomnia—Memantine—Alzheimer's disease	6.43e-05	0.000263	CcSEcCtD
Risperidone—Vomiting—Galantamine—Alzheimer's disease	6.42e-05	0.000263	CcSEcCtD
Risperidone—Gastrointestinal pain—Donepezil—Alzheimer's disease	6.4e-05	0.000262	CcSEcCtD
Risperidone—Paraesthesia—Memantine—Alzheimer's disease	6.38e-05	0.000261	CcSEcCtD
Risperidone—Rash—Galantamine—Alzheimer's disease	6.37e-05	0.000261	CcSEcCtD
Risperidone—Dermatitis—Galantamine—Alzheimer's disease	6.36e-05	0.00026	CcSEcCtD
Risperidone—Dyspnoea—Memantine—Alzheimer's disease	6.34e-05	0.000259	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	6.33e-05	0.000259	CcSEcCtD
Risperidone—Headache—Galantamine—Alzheimer's disease	6.33e-05	0.000259	CcSEcCtD
Risperidone—Somnolence—Memantine—Alzheimer's disease	6.32e-05	0.000259	CcSEcCtD
Risperidone—Insomnia—Rivastigmine—Alzheimer's disease	6.29e-05	0.000257	CcSEcCtD
Risperidone—Dyspepsia—Memantine—Alzheimer's disease	6.26e-05	0.000256	CcSEcCtD
Risperidone—Paraesthesia—Rivastigmine—Alzheimer's disease	6.24e-05	0.000256	CcSEcCtD
Risperidone—Urticaria—Donepezil—Alzheimer's disease	6.22e-05	0.000255	CcSEcCtD
Risperidone—Dyspnoea—Rivastigmine—Alzheimer's disease	6.2e-05	0.000254	CcSEcCtD
Risperidone—Abdominal pain—Donepezil—Alzheimer's disease	6.19e-05	0.000253	CcSEcCtD
Risperidone—Body temperature increased—Donepezil—Alzheimer's disease	6.19e-05	0.000253	CcSEcCtD
Risperidone—Somnolence—Rivastigmine—Alzheimer's disease	6.18e-05	0.000253	CcSEcCtD
Risperidone—Decreased appetite—Memantine—Alzheimer's disease	6.18e-05	0.000253	CcSEcCtD
Risperidone—Gastrointestinal disorder—Memantine—Alzheimer's disease	6.14e-05	0.000251	CcSEcCtD
Risperidone—Fatigue—Memantine—Alzheimer's disease	6.13e-05	0.000251	CcSEcCtD
Risperidone—Dyspepsia—Rivastigmine—Alzheimer's disease	6.12e-05	0.000251	CcSEcCtD
Risperidone—Pain—Memantine—Alzheimer's disease	6.08e-05	0.000249	CcSEcCtD
Risperidone—Constipation—Memantine—Alzheimer's disease	6.08e-05	0.000249	CcSEcCtD
Risperidone—Decreased appetite—Rivastigmine—Alzheimer's disease	6.04e-05	0.000247	CcSEcCtD
Risperidone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	6e-05	0.000246	CcSEcCtD
Risperidone—Nausea—Galantamine—Alzheimer's disease	6e-05	0.000246	CcSEcCtD
Risperidone—Fatigue—Rivastigmine—Alzheimer's disease	5.99e-05	0.000245	CcSEcCtD
Risperidone—Pain—Rivastigmine—Alzheimer's disease	5.95e-05	0.000243	CcSEcCtD
Risperidone—Constipation—Rivastigmine—Alzheimer's disease	5.95e-05	0.000243	CcSEcCtD
Risperidone—Feeling abnormal—Memantine—Alzheimer's disease	5.86e-05	0.00024	CcSEcCtD
Risperidone—Gastrointestinal pain—Memantine—Alzheimer's disease	5.81e-05	0.000238	CcSEcCtD
Risperidone—Hypersensitivity—Donepezil—Alzheimer's disease	5.77e-05	0.000236	CcSEcCtD
Risperidone—Feeling abnormal—Rivastigmine—Alzheimer's disease	5.73e-05	0.000235	CcSEcCtD
Risperidone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	5.69e-05	0.000233	CcSEcCtD
Risperidone—Urticaria—Memantine—Alzheimer's disease	5.65e-05	0.000231	CcSEcCtD
Risperidone—Abdominal pain—Memantine—Alzheimer's disease	5.62e-05	0.00023	CcSEcCtD
Risperidone—Body temperature increased—Memantine—Alzheimer's disease	5.62e-05	0.00023	CcSEcCtD
Risperidone—Asthenia—Donepezil—Alzheimer's disease	5.62e-05	0.00023	CcSEcCtD
Risperidone—Pruritus—Donepezil—Alzheimer's disease	5.54e-05	0.000227	CcSEcCtD
Risperidone—Urticaria—Rivastigmine—Alzheimer's disease	5.52e-05	0.000226	CcSEcCtD
Risperidone—Body temperature increased—Rivastigmine—Alzheimer's disease	5.5e-05	0.000225	CcSEcCtD
Risperidone—Abdominal pain—Rivastigmine—Alzheimer's disease	5.5e-05	0.000225	CcSEcCtD
Risperidone—Diarrhoea—Donepezil—Alzheimer's disease	5.36e-05	0.000219	CcSEcCtD
Risperidone—Hypersensitivity—Memantine—Alzheimer's disease	5.24e-05	0.000214	CcSEcCtD
Risperidone—Dizziness—Donepezil—Alzheimer's disease	5.18e-05	0.000212	CcSEcCtD
Risperidone—Hypersensitivity—Rivastigmine—Alzheimer's disease	5.12e-05	0.00021	CcSEcCtD
Risperidone—Asthenia—Memantine—Alzheimer's disease	5.1e-05	0.000209	CcSEcCtD
Risperidone—Pruritus—Memantine—Alzheimer's disease	5.03e-05	0.000206	CcSEcCtD
Risperidone—Asthenia—Rivastigmine—Alzheimer's disease	4.99e-05	0.000204	CcSEcCtD
Risperidone—Vomiting—Donepezil—Alzheimer's disease	4.98e-05	0.000204	CcSEcCtD
Risperidone—Rash—Donepezil—Alzheimer's disease	4.94e-05	0.000202	CcSEcCtD
Risperidone—Dermatitis—Donepezil—Alzheimer's disease	4.93e-05	0.000202	CcSEcCtD
Risperidone—Pruritus—Rivastigmine—Alzheimer's disease	4.92e-05	0.000201	CcSEcCtD
Risperidone—Headache—Donepezil—Alzheimer's disease	4.9e-05	0.000201	CcSEcCtD
Risperidone—Diarrhoea—Memantine—Alzheimer's disease	4.86e-05	0.000199	CcSEcCtD
Risperidone—Diarrhoea—Rivastigmine—Alzheimer's disease	4.76e-05	0.000195	CcSEcCtD
Risperidone—Dizziness—Memantine—Alzheimer's disease	4.7e-05	0.000192	CcSEcCtD
Risperidone—Nausea—Donepezil—Alzheimer's disease	4.65e-05	0.00019	CcSEcCtD
Risperidone—Dizziness—Rivastigmine—Alzheimer's disease	4.6e-05	0.000188	CcSEcCtD
Risperidone—Vomiting—Memantine—Alzheimer's disease	4.52e-05	0.000185	CcSEcCtD
Risperidone—Rash—Memantine—Alzheimer's disease	4.48e-05	0.000183	CcSEcCtD
Risperidone—Dermatitis—Memantine—Alzheimer's disease	4.48e-05	0.000183	CcSEcCtD
Risperidone—Headache—Memantine—Alzheimer's disease	4.45e-05	0.000182	CcSEcCtD
Risperidone—Vomiting—Rivastigmine—Alzheimer's disease	4.42e-05	0.000181	CcSEcCtD
Risperidone—Rash—Rivastigmine—Alzheimer's disease	4.38e-05	0.000179	CcSEcCtD
Risperidone—Dermatitis—Rivastigmine—Alzheimer's disease	4.38e-05	0.000179	CcSEcCtD
Risperidone—Headache—Rivastigmine—Alzheimer's disease	4.36e-05	0.000178	CcSEcCtD
Risperidone—Nausea—Memantine—Alzheimer's disease	4.22e-05	0.000173	CcSEcCtD
Risperidone—Nausea—Rivastigmine—Alzheimer's disease	4.13e-05	0.000169	CcSEcCtD
Risperidone—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	3.05e-06	3.54e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	3.05e-06	3.53e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—AKT1—Alzheimer's disease	3.05e-06	3.53e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	3.04e-06	3.53e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	3.04e-06	3.53e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	3.04e-06	3.52e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	3.04e-06	3.52e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	3.03e-06	3.51e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.02e-06	3.5e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	3.02e-06	3.5e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	3.02e-06	3.5e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	3.01e-06	3.48e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—LPL—Alzheimer's disease	3e-06	3.48e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	2.97e-06	3.45e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	2.96e-06	3.44e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.96e-06	3.43e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	2.94e-06	3.41e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.93e-06	3.39e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MAPK8—Alzheimer's disease	2.92e-06	3.39e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	2.92e-06	3.39e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—AKT1—Alzheimer's disease	2.92e-06	3.38e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	2.91e-06	3.37e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PPARG—Alzheimer's disease	2.91e-06	3.37e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—INS—Alzheimer's disease	2.91e-06	3.37e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	2.9e-06	3.36e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.9e-06	3.36e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	2.89e-06	3.35e-05	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.89e-06	3.35e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	2.89e-06	3.35e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	2.87e-06	3.33e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	2.87e-06	3.33e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	2.87e-06	3.32e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	2.86e-06	3.32e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—INS—Alzheimer's disease	2.86e-06	3.31e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	2.86e-06	3.31e-05	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—AKT1—Alzheimer's disease	2.85e-06	3.31e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—INS—Alzheimer's disease	2.85e-06	3.31e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—INS—Alzheimer's disease	2.85e-06	3.3e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	2.85e-06	3.3e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.84e-06	3.29e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.83e-06	3.28e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CASP3—Alzheimer's disease	2.83e-06	3.28e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—VEGFA—Alzheimer's disease	2.82e-06	3.27e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	2.81e-06	3.26e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	2.81e-06	3.26e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	2.81e-06	3.26e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.81e-06	3.26e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—IL6—Alzheimer's disease	2.81e-06	3.26e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	2.81e-06	3.25e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	2.81e-06	3.25e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	2.8e-06	3.25e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	2.8e-06	3.24e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	2.79e-06	3.24e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	2.78e-06	3.23e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.77e-06	3.21e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.77e-06	3.21e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	2.76e-06	3.21e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	2.76e-06	3.2e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	2.76e-06	3.2e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	2.75e-06	3.19e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	2.74e-06	3.18e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—NOS3—Alzheimer's disease	2.73e-06	3.16e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.72e-06	3.15e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	2.71e-06	3.14e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.7e-06	3.13e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—VEGFA—Alzheimer's disease	2.7e-06	3.13e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.64e-06	3.06e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	2.63e-06	3.05e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	2.63e-06	3.04e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	2.62e-06	3.03e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	2.6e-06	3.01e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	2.6e-06	3.01e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	2.59e-06	3e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	2.59e-06	3e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.58e-06	2.99e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	2.58e-06	2.99e-05	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.58e-06	2.99e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	2.57e-06	2.98e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	2.56e-06	2.97e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	2.55e-06	2.96e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.55e-06	2.95e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	2.55e-06	2.95e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	2.54e-06	2.94e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.53e-06	2.93e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	2.52e-06	2.92e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—APOE—Alzheimer's disease	2.52e-06	2.92e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	2.52e-06	2.92e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	2.51e-06	2.91e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	2.5e-06	2.9e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—NOS3—Alzheimer's disease	2.5e-06	2.9e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	2.49e-06	2.89e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.49e-06	2.89e-05	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.49e-06	2.88e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	2.48e-06	2.87e-05	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	2.47e-06	2.87e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	2.46e-06	2.86e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	2.45e-06	2.85e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	2.45e-06	2.84e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	2.45e-06	2.84e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	2.43e-06	2.82e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.43e-06	2.82e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	2.43e-06	2.82e-05	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	2.41e-06	2.79e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	2.4e-06	2.78e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	2.38e-06	2.76e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.38e-06	2.76e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.37e-06	2.75e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	2.37e-06	2.75e-05	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.37e-06	2.74e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	2.37e-06	2.74e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.36e-06	2.73e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.35e-06	2.72e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	2.35e-06	2.72e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	2.35e-06	2.72e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	2.34e-06	2.71e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	2.33e-06	2.7e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	2.29e-06	2.65e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	2.28e-06	2.64e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.26e-06	2.62e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	2.26e-06	2.62e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	2.25e-06	2.61e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	2.25e-06	2.6e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	2.23e-06	2.59e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	2.2e-06	2.55e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PPARG—Alzheimer's disease	2.19e-06	2.54e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	2.19e-06	2.54e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	2.18e-06	2.53e-05	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.18e-06	2.53e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	2.17e-06	2.51e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	2.16e-06	2.51e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	2.16e-06	2.5e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—INS—Alzheimer's disease	2.15e-06	2.49e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	2.15e-06	2.49e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	2.15e-06	2.49e-05	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.15e-06	2.49e-05	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.14e-06	2.48e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—Alzheimer's disease	2.13e-06	2.47e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	2.13e-06	2.47e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	2.12e-06	2.46e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	2.12e-06	2.45e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	2.11e-06	2.45e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	2.11e-06	2.45e-05	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.1e-06	2.44e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.09e-06	2.42e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	2.08e-06	2.42e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.08e-06	2.41e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	2.07e-06	2.4e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	2.07e-06	2.4e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.07e-06	2.4e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—Alzheimer's disease	2.04e-06	2.37e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.03e-06	2.36e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—INS—Alzheimer's disease	2.03e-06	2.35e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.02e-06	2.35e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.02e-06	2.34e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.99e-06	2.31e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.99e-06	2.3e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.99e-06	2.3e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.98e-06	2.3e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.96e-06	2.27e-05	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.95e-06	2.27e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.95e-06	2.26e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL6—Alzheimer's disease	1.95e-06	2.26e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.95e-06	2.26e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	1.95e-06	2.26e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.95e-06	2.26e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.94e-06	2.25e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.94e-06	2.24e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.92e-06	2.23e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.92e-06	2.22e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.92e-06	2.22e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.91e-06	2.21e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.91e-06	2.21e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.9e-06	2.2e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.89e-06	2.19e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL6—Alzheimer's disease	1.87e-06	2.16e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.86e-06	2.15e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.85e-06	2.14e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.84e-06	2.13e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.84e-06	2.13e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.83e-06	2.12e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—Alzheimer's disease	1.81e-06	2.1e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.81e-06	2.09e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.8e-06	2.09e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	1.8e-06	2.09e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.79e-06	2.07e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	1.78e-06	2.07e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.78e-06	2.06e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.78e-06	2.06e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.77e-06	2.06e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.77e-06	2.05e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	1.75e-06	2.03e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.72e-06	2e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	1.72e-06	2e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.68e-06	1.95e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.68e-06	1.95e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.67e-06	1.93e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL6—Alzheimer's disease	1.66e-06	1.92e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.66e-06	1.92e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.65e-06	1.92e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	1.64e-06	1.91e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.64e-06	1.9e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	1.64e-06	1.9e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.63e-06	1.88e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.62e-06	1.88e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AKT1—Alzheimer's disease	1.59e-06	1.84e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.58e-06	1.83e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.57e-06	1.82e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.56e-06	1.8e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.55e-06	1.8e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.55e-06	1.8e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AKT1—Alzheimer's disease	1.54e-06	1.79e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.54e-06	1.78e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	1.53e-06	1.77e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	1.53e-06	1.77e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.51e-06	1.75e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	1.5e-06	1.74e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	1.5e-06	1.74e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.45e-06	1.68e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.44e-06	1.67e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	1.4e-06	1.62e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.39e-06	1.61e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	1.38e-06	1.6e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	1.38e-06	1.6e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.36e-06	1.58e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.36e-06	1.58e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.35e-06	1.57e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.34e-06	1.55e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	1.33e-06	1.55e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.33e-06	1.54e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—INS—Alzheimer's disease	1.32e-06	1.54e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	1.29e-06	1.5e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	1.27e-06	1.47e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.27e-06	1.47e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.25e-06	1.45e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.25e-06	1.45e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.25e-06	1.44e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.24e-06	1.44e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	1.22e-06	1.42e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	1.17e-06	1.36e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.16e-06	1.35e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	1.15e-06	1.34e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	1.15e-06	1.33e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.15e-06	1.33e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	1.14e-06	1.32e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	1.13e-06	1.31e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.06e-06	1.23e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.05e-06	1.22e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AKT1—Alzheimer's disease	8.67e-07	1e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AKT1—Alzheimer's disease	8.17e-07	9.47e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	5.34e-07	6.19e-06	CbGpPWpGaD
